A study published in The American Journal of Gastroenterology outlined several treatment options for gastroesophageal reflux disease patients experiencing persistent symptoms after proton pump inhibitor therapy.
GI & Endoscopy
Los Angeles-based Cedars-Sinai Medical Center researcher Mark Pimentel, MD, partnered with Salix Pharmaceuticals to continue researching gut microbiome-based treatments, the Los Angeles Business Journal reports.
Ronald Lynn White, MD, is a gastroenterologist at Rogers, Ark.-based Mercy Clinic Gastroenterology.
A new endoscopy suite opened at Hendricks (Ind.) Regional Health's Danville hospital, the Hendricks County Flyer reported.
A new analysis from Kaiser Permanente networks in northern and southern California found nearly 70 percent of patients who died of colorectal cancer were not up to date on their screenings for the condition, Gastroenterology and Endoscopy News reported.
Advertisement
RedHill Biopharma's Crohn's disease drug, RHB-104, successfully met its primary and secondary endpoints, achieving remission at 26 weeks, Reuters reports.
Fight Colorectal Cancer and PGA Tour professional Tom Lehman are partnering to promote Fight CRC.
Researchers at Barcelona, Spain-based Hospital Del Mar Medical Research Institute discovered inhibiting the Jagged 1 protein in mice prevents colon and rectal tumor growth, according to research published in Nature Communications.
Here are the five most popular gastroenterology and endoscopy stories for the week of July 26 to August 1, 2018.
Takeda released its first quarter 2018 revenue numbers.